Concat us[email protected]
Shopping Cart

No products in the cart.

🔍
CLSI NBS08-2019

CLSI NBS08-2019

$48.10

Newborn Screening for Hemoglobinopathies

Published By Publication Date Number of Pages
CLSI 2019-10-28 120
PDF Format Searchable Printable Preview Now
Guaranteed Safe Checkout
Category:

If you have any questions, feel free to reach out to our online customer service team by clicking on the bottom right corner. We’re here to assist you 24/7.
Email:[email protected]

This guideline describes the recommended protocols for detecting hemoglobinopathies and thalassemias by population-based newborn screening using dried blood spot specimens. Early, presymptomatic detection to identify newborns with abnormal hemoglobins is critical because it improves treatment effectiveness.

Related products

  • CLSI NBS02-A2-2013

    CLSI NBS02-A2-2013

    Newborn Screening Follow-up Published By Publication Date Number of Pages CLSI 2013-05-01 40

    $48.10 Add to cart
  • CLSI NBS06-A-2013

    CLSI NBS06-A-2013

    Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles…

    $48.10 Add to cart
  • CLSI NBS07-2017

    CLSI NBS07-2017

    Newborn Blood Spot Screening for Pompe Disease by Lysosomal Acid Alpha-Glucosidase Activity Assays Published By…

    $48.10 Add to cart
  • CLSI NBS01-A6-2013

    CLSI NBS01-A6-2013

    Blood Collection on Filter Paper for Newborn Screening Programs Published By Publication Date Number of…

    $48.10 Add to cart
  • CLSI NBS04-2017

    CLSI NBS04-2017

    Newborn Screening by Tandem Mass Spectrometry Published By Publication Date Number of Pages CLSI 2017-05-01…

    $48.10 Add to cart
CLSI NBS08-2019
$48.10